Concepedia

Combination of Resveratrol and PARP inhibitor Olaparib efficiently deregulates homologous recombination repair pathway in breast cancer cells through inhibition of TIP60-mediated chromatin relaxation

Saptarshi Sinha, Subarno Paul, S. Acharya, Chinmay Das, Somya Ranjan Dash, Subhasmita Bhal, Rajalaxmi Pradhan, Biswajit Das, Chanakya Nath Kundu

Medical Oncology · 2024 · 11 citations · 18 references

DOI

References

18

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2021 · 109.5K citations · Full text

Re-epithelialization and immune cell behaviour in an ex vivo human skin model

Ana Rakita, Nenad Nikolić, Michael Mildner et al. · Scientific Reports · 2020 · 8.1K citations · Full text

ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Cherrie K. Donawho, Yan Luo, Yanping Luo et al. · Clinical Cancer Research · 2007 · 762 citations · Full text

Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.

Lucio Tentori, Carlo Leonetti, Marco Scarsella et al. · PubMed · 2003 · 204 citations

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Solène De Talhouet, Julien Péron, Aurélie Vuilleumier et al. · Scientific Reports · 2020 · 122 citations · Full text